drugset / Trial / NCT06756711

Combination of Supplements for Treating Autistic Spectrum Disorder

NCT06756711 ↗

Enrolling by invitation 40 enrolled Fundatia Bio-Forum
RandomizedCrossoverQuadruple-blindTreatment

Summary

A pilot study to compare the efficacy of a combination of apitherapy supplements versus placebo in children with autistic spectrum disorder.

Timeline

Start
2024-12-10
Primary completion
2025-09
Completion
2025-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Apicol 12 gamma Unknown — —
Subject Laptisor de matca activat Unknown — —
Subject Telom R Cerebral Unknown — —